Delivery Order SPE2DB20D3101-SPE2DB25FRJJ2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal spray with a ceiling value of $1,139.25. This competitively awarded, firm fixed-price delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.10 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays. The contract, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this order. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,137.67 delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on March 18, 2025, with completion targeted for March 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,259.24 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, with an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 21, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $5,648.10 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of August 6, 2025. This competitive award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,748.50 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a single-award transaction under a competitive procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with a contract ceiling value of $1,453.86. This competitively awarded, firm fixed-price delivery order, issued on September 5, 2025, is set to conclude by September 8, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under a larger contracting vehicle. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of July 30, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in the same city. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,252.20 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays. This contract, issued on September 8, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 9, 2025. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with performance of work...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRJJ2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal sprays, with a ceiling value of $1,128.54. The contract, issued on May 2, 2025, with an ultimate completion date of May 5, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Valtoco (diazepam) nasal spray is a rapid-acting anxiolytic medication used in acute medical settings. This delivery order reflects AmerisourceBergen Drug Corp's established role as a critical pharmaceutical supplier to the Defense Health Agency and broader federal military healthcare systems. The company's competitively awarded federal contracts demonstrate its capability to fulfill specialized medical supply requirements across therapeutic domains, supporting military healthcare operations and readiness through the DLA's comprehensive pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/2/25 |